Results for &quot;&quot;Interferon beta-1b&quot;&quot;[mesh_terms]

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Kathryn C Fitzgerald, Kassandra L Munger, Hans-Peter Hartung, Mark S Freedman, Xavier Montalbán, Gilles Edan, Eva-Maria Wicklein, Ernst-Wilhelm Radue, Ludwig Kappos, Christoph Pohl, Alberto Ascherio

Annals of neurology 2017;82(1):20-29

A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type.

Mohammad Abdollahi, Roja Rahimi, Shekoufeh Nikfar

Clinical therapeutics 2011;32(11):1871-88

Effects of interferon β-1a and interferon β-1b monotherapies on selected serum cytokines and nitrite levels in patients with relapsing-remitting multiple sclerosis: a 3-year longitudinal study.

Adam Stępień, Małgorzata Chalimoniuk, Natalia Lubina-Dąbrowska, Stanisław J Chrapusta, Henrik Galbo, Józef Langfort

Neuroimmunomodulation 2014;20(4):213-22

Effect of interferon beta-1b in MS: assessment of annual accumulation of PD/T2 activity on MRI. UBC MS/MRI Analysis Group and the MS Study Group.

G J Zhao, R A Koopmans, D K Li, L Bedell, D W Paty

Neurology 2000;54(1):200-6

Early diagnosis, monitoring, and treatment of optic neuritis.

Jane W Chan

The neurologist 2012;18(1):23-31

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial.

Chuan Li, Fengming Luo, Chengwu Liu, Nian Xiong, Zhihua Xu, Wei Zhang, Ming Yang, Ye Wang, Dan Liu, Chao Yu, Jia Zeng, Li Zhang, Duo Li, Yanbin Liu, Mei Feng, Ruoyang Liu, Jiandong Mei, Senyi Deng, Zhen Zeng, Yuanhong He, Haiyan Liu, Zhengyu Shi, Meng Duan, Deying Kang, Jiayu Liao, Weimin Li, Lunxu Liu

Annals of medicine 2021;53(1):391-401

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.

Jan Dörr, Stephanie Ohlraun, Horst Skarabis, Friedemann Paul

Trials 2012;13():15

Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b.

S Narayanan, N De Stefano, G S Francis, R Arnaoutelis, Z Caramanos, D L Collins, D Pelletier, J P Antel, D L Arnold

Journal of neurology 2002;248(11):979-86

The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.

Simona Damiano, Anna Sasso, Bruna De Felice, Giuseppe Terrazzano, Vincenzo Bresciamorra, Antonio Carotenuto, Nicola S Orefice, Giuseppe Orefice, Giovanni Vacca, Annamaria Belfiore, Mariarosaria Santillo, Paolo Mondola

Brain research bulletin 2016;118():1-6

Vitamin D, smoking, EBV, and long-term cognitive performance in MS: 11-year follow-up of BENEFIT.

Marianna Cortese, Kassandra L Munger, Elena H Martínez-Lapiscina, Christian Barro, Gilles Edan, Mark S Freedman, Hans-Peter Hartung, Xavier Montalbán, Frederick W Foley, Iris Katharina Penner, Bernhard Hemmer, Edward J Fox, Sven Schippling, Eva-Maria Wicklein, Ludwig Kappos, Jens Kuhle, Alberto Ascherio

Neurology 2020;94(18):e1950-e1960

In vivo effects of recombinant-interferon-beta1b treatment on polymorphonuclear cell and monocyte functions and on T-cell-mediated antibacterial activity in patients with relapsing-remitting multiple sclerosis.

A B Maffione, E Tatò, S Losito, C Nacci, V Mitolo, M Troiano, M Ruggieri, P Livrea, E Jirillo

Immunopharmacology and immunotoxicology 2000;22(1):1-18

The uninvited guest. An overview of multiple sclerosis.

Rebecca J Andes

Advance for nurse practitioners 2010;16(1):37-40; quiz 41

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

Merja Soilu-Hänninen, Julia Aivo, Britt-Marie Lindström, Irina Elovaara, Marja-Liisa Sumelahti, Markus Färkkilä, Pentti Tienari, Sari Atula, Taneli Sarasoja, Lauri Herrala, Irma Keskinarkaus, Johanna Kruger, Timo Kallio, Maria A Rocca, Massimo Filippi

Journal of neurology, neurosurgery, and psychiatry 2012;83(5):565-71

Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis.

Raffaele Palladino, Marcello Moccia, Antonio Carotenuto, Cinzia Valeria Russo, Maria Triassi, Roberta Lanzillo, Vincenzo Brescia Morra

Multiple sclerosis and related disorders 2017;10():90-96